Columbia Financial, Inc. (CLBK) Balance Sheet

The balance sheet expanded from $10.6B in 2024Q1 to $12.2B in 2026Q2, with the most significant jump occurring in 2026Q2 (up $1.2B sequentially). This acceleration appears tied to the Freehold Bank integration and continued multi-family lending. However, the composition of growth warrants scrutiny: cash balances surged to $1.1B in 2026Q2 from $276.8M in 2026Q1, suggesting a possible liquidity build-up ahead of deployment. The equity base remained flat at $1.2B, indicating that asset growth is being funded primarily by liabilities, likely deposits and wholesale borrowings.

While the provided data lacks explicit deposit composition, the bank's heavy reliance on CDs and money market accounts, as noted in the company intelligence, implies a higher beta to rising rates. The efficiency ratio improved to 35.9% in 2026Q1 from 43.9% in 2026Q2, but this may reflect revenue timing rather than structural cost improvement. The absence of loan-to-deposit figures limits direct assessment, but the rapid asset growth without a commensurate rise in core deposits suggests an increasing reliance on wholesale funding, which could elevate funding costs and compress margins.

This dramatic provision increase suggests a significant deterioration in credit quality or a change in economic outlook, particularly given the bank's concentration in New Jersey multi-family and CRE loans. The prior quarter's provision was minimal, so this spike may indicate specific credit events or a forward-looking adjustment under CECL. Investors should monitor whether this is a one-time charge or the beginning of a trend, as it could signal weakening in the bank's core asset quality. The net charge-offs are not disclosed, but the provision far exceeds any recent loss history, implying management's expectation of higher future losses.

The equity-to-assets ratio of approximately 10% is typical for a bank, but the low ROE (1.2% in 2026Q2) suggests that the bank is not generating sufficient returns on its capital base. The MHC structure allows for capital retention, but the lack of dividends and minimal buybacks (as per cash flow analysis) indicates a conservative approach. The provision spike in 2026Q2 will directly reduce capital, potentially pressuring regulatory ratios. However, the bank's cash position of $1.1B provides a buffer, though it is not deployed efficiently, as evidenced by the low NIM.

This significant cash accumulation suggests a strategic shift towards liquidity preservation, possibly in response to deposit competition or to fund upcoming loan commitments. The investment securities portfolio also grew to $10.2B, indicating that the bank is deploying excess liquidity into higher-yielding assets. However, the low NIM of 0.5% suggests that the yield on these assets is not sufficient to offset funding costs. The reliance on wholesale funding, if any, is not directly visible, but the cash buffer provides a cushion against deposit outflows. Investors should monitor whether this cash is deployed into loans or remains idle, as it could impact future profitability.

The stable NIM of 0.5% masks the underlying pressure from rising deposit costs. With the NY/NJ market experiencing intense competition for deposits, the bank's cost of funds is likely rising, which could erode the spread. The legacy residential loan book, which carries lower fixed rates, may not reprice as quickly as deposits, leading to margin compression. The 2026Q2 provision spike also suggests that credit costs are rising, which could further pressure earnings. Without explicit guidance, investors should monitor deposit beta and loan yields to assess the trajectory of NIM.